Pressurised metered dose inhalers (pMDIs) with integrated flow rate guidance. Source: International Congress 2017 – Pulmonary drug and devices delivery Year: 2017
Objective measurement of inhalation profiles in patients using metered dose inhalers (MDIs) Source: Annual Congress 2011 - Drug delivery and pharmacokinetics I Year: 2011
Comparison of proficiency of pressurized metered dose inhaler (pMDI) use with asthma control Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma Year: 2008
Technique: the usual problem of metered dose inhalers Source: Eur Respir J 2002; 20: Suppl. 38, 503s Year: 2002
Asthma control with a breath-actuated pressurised metered dose inhaler (BAI) and prevalence of oral candidiasis: a prescribing claims study of 1701 patients prescribed a traditional pressurised metered dose inhaler (MDI) plus spacer or a BAI Source: Eur Respir J 2002; 20: Suppl. 38, 78s Year: 2002
Critical handling errors with dry-powder, metered dose and soft-mist inhaler devices in an observational COPD study Source: International Congress 2019 – COPD treatment: clinical trials, cohorts and inhaler device studies Year: 2019
Ten questions about metered dose inhalers: the quality of patient‘s knowledge about aerosol therapy Source: Eur Respir J 2005; 26: Suppl. 49, 514s Year: 2005
Device handling study of a novel breath-actuated inhaler Synchrobreathe vs pMDI Source: International Congress 2019 – COPD treatment: clinical trials, cohorts and inhaler device studies Year: 2019
Assessment of relative potency of salbutamol administered via a metered-dose inhaler plus spacer or via a dry-powder inhaler in asthma patients Source: Eur Respir J 2006; 28: Suppl. 50, 209s Year: 2006
Comparison between traditional and nontraditional add-on devices used with pressurised metered-dose inhalers Source: ERJ Open Res, 6 (4) 00073-2020; 10.1183/23120541.00073-2020 Year: 2020
In vitro evaluation of spacers in comparison with T-adapters in mechanical ventilation with pressurized metered dose inhalers (pMDI) and vibrating mesh nebulizer. Source: International Congress 2019 – COPD and other specific entities in intensive care unit medicine Year: 2019
Assessment of the suitability of filters for use in clinical studies with an HFA fluticasone propionate pressurized metered dose inhaler (pMDI) and a valved holding chamber (VHC) Source: Annual Congress 2011 - Lung function today and tomorrow II Year: 2011
Salbutamol delivered via a new multi-dose dry powder inhaler is as safe and efficacious as a pressurised metered dose inhaler in children aged 6-12 years Source: Eur Respir J 2002; 20: Suppl. 38, 501s Year: 2002
In vitro comparison of aerosol characteristics of HFA albuterol (salbutamol) pressurized metered dose inhaler (pMDI) formulation from three valved holding chambers (VHCs) Source: Annual Congress 2011 - Drug delivery and pharmacokinetics II Year: 2011
Correct and incorrect use of metered dose inhalers by patients and related factors Source: Annual Congress 2007 - Nursing interventions in the prevention and management of respiratory disease Year: 2007
Two-tone trainer maintains a slow inhalation rate when using a metered dose inhaler (MDI) Source: Eur Respir J 2005; 26: Suppl. 49, 47s Year: 2005
Bronchodilator response to salbutamol administered through metered-dose inhaler plus spacer or dry-powder inhaler in asthmatic patients Source: Eur Respir J 2001; 18: Suppl. 33, 101s Year: 2001
The effect of Clip-tone® and its smartphone application on optimization of metered-dose inhaler inhalation technique Source: Virtual Congress 2020 – How to overcome deficiencies in skills in bedside training by virtual tools and simulation- where do we go? Year: 2020
Oral manifestations in asthmatic patients using metered dose inhaler and dry powder inhaler Source: International Congress 2019 – Innovations in primary care assessment and management Year: 2019
Impact of inhalation delay on medication delivery from a salbutamol HFA pressurized metered dose inhaler used with and without a new prototype portable valved holding chamber Source: International Congress 2019 – COPD treatment: clinical trials, cohorts and inhaler device studies Year: 2019